Events on 16 March 2022

16.00 Modules: a new approach to Specialist Portfolio training
Sarah May, Deputy Chief Executive, IBMS

09.00 Preparing to pass the HSD Chris Ward, Head of Examinations, IBMS

14.00 Pre-empting problems – may the workforce be with you Charley Frampton, Berkshire & Surrey Pathology Services
15.00 The exit interview – a meaningful goodbye Joanna Frost,
Path Links North Lincolnshire & Goole NHS Foundation Trust
16.00 The importance of good laboratory design on staff health and wellbeing
Ian Cocking, Leeds Teaching Hospitals NHS Trust
16.30 Motivating a tired and exhausted workforce

Chair: Mike Palmer
14.00 Mapping the genomic architecture of COVID-19, a discovery that may aid in the fight against SARS-CoV-2 infection Dr Yasser El-Sherbiny, Nottingham Trent University
14.30 EUCAST update 2022
Pegah Hafezi, North Bristol NHS Trust
15.00 Antibiotic resistance spillover into wildlife - using birds of prey as signal species
Professor Mark Fielder, Kingston University
16.00 Whats new in mycology?
Prof. Elizabeth Johnson, UK Health Security Agency
16.30 Invasive Magnusiomyces capitatus infection in a patient with neutropenic sepsis Michael Collins, University Hospitals of Derby and Burton
NHS Foundation Trust

Chair: Catherine Lorenzen
14.00 Column agglutination technology Kerry Dowling,
University Hospital Southampton NHS Foundation Trust
14.30 Technology – solid phase Samantha Reynolds, University Hospitals Plymouth NHS Trust
15.00 Microarray technology
Dr Janine Robb, Quotient, Edinburgh
16.00 Regular transfusion –- the patient experience Dipika Shah, UKNEQAS Haematology and Blood Transfusion
16.30 The Cambridge Cellular Therapy Laboratory
Sarah Albon, Cambridge University Hospitals NHS Foundation Trust

Viral Infections Chair Jayne Harwood 14.00 Viral infections in risk groups
– infections in pregnancy
Dr Sheila Waugh, The Newcastle upon Tyne Hospitals NHS Foundation Trust
14.30 Viral infections in risk groups
– infections in childhood
Emma Davies, UK Health Security Agency
15.00 Viral infections in risk groups – infections in prisons Jayne Harwood,
The Newcastle upon Tyne Hospitals NHS Foundation Trust
16.00 Hepatitis
C - elimination of a treatable pandemic. Where are we now? Dr Brendan Healy, Public Health Wales
16.30 Rabies
Prof Anthony Fooks, Animal and Plant Health Agency

Chair: Dr Guy Orchard
14.00
Immunohistochemistry (IHC) in breast pathology
Keeley Thwaites, Barking Havering and Redbridge University Hospitals NHS Trust
14.30 Lymphoma pathology:
The impact of immunohistochemistry, past and present
Dr José Cabeçadas’s, Oncology Institute of Lisbon, Portugal
16.00 Head and neck pathology: A new module from UK
NEQAS for ICC & ISH
Suzanne Parry,
UK NEQAS ICC & ISH
16.30 Clinical aspects of head and neck pathology
Dr Ann Sandison, Guy’s and St.Thomas’ NHS Foundation Trust

Chair: Ashley Ballard
9.00 Consultant scientist reporting
– 2 years on
Patrick Kumah, University Hospitals of Derby and Burton NHS Foundation Trust
9.30 Genomic testing in histopathology: An ethical perspective Dr Mahomed Dada,
University Hospitals of Derby & Burton NHS Foundation Trust
10.30
Instrumentation – friend or foe?
Rob Hughes, UK NEQAS Cellular Pathology Technique
11.00 Digital pathology – pilot to practice
William Davies, Worcestershire Acute Hospitals NHS Trust
11.30 Digital pathology – to infinity and beyond
Dr David Brettle, Leeds Cancer Centre, St. James’s University Hospital

Chair: Graham Wilson
14.00 Future of Clinical Biochemistry
– health informatics and bioinformatics Prof. Dimitris Grammatopoulos, Warwick Medical School and University Hospitals of Coventry and Warwickshire NHS Trust
14.30 A case of pseudohyperkalaemia and pseudo- hypercalcaemia in a patient with acute myeloid leukaemia with thrombocytosis Andrew Connor, PathLinks, North
East Lincolnshire and Goole NHS Foundation Trust
14.50 A case of myeloma diagnosed from a random urine protein
Charlotte Atkin, Nottingham University Hospitals NHS Trust
15.10 A biochemistry Biomedical Scientist
– roles and career development beyond the laboratory Sheri Scott, Nottingham Trent University
16.00 Liver Pandemic
- Can the Laboratory save us?
Dr Andrew Fraser, Queen Elizabeth University Hospital, Glasgow
16.30 Biochemical screening for phaeochromocytoma and paraganglioma (PPGL)
Dr Craig Livie, NHS Greater Glasgow and Clyde

Chair: Martin McFadden
9.00 Tumour markers for today and tomorrow
Prof. Joe Duffy, St Vincent’s University Hospital, Dublin
9.30 Essential contribution of laboratory diagnostics in COVID-19
Prof. Giuseppe Lippi, University of Verona, Italy
10.30 Biomarkers in the diagnosis of sepsis
Andrew Teggert, South Tees Hospitals NHS Foundation Trust
11.00 Urgent Biochemistry – impact of the 1 hour TAT
in the ED, does it benefit patients? Prof. Richard Body, University of Manchester
11.30 COVID-19: Cross skilling of healthcare workers Becky Kay, Guy’s and St Thomas’ NHS Foundation Trust 12.45 Clinical Scientist Experiential Route and Process and
Q&A with the Clinical Chemistry Higher Specialist Diploma (HSD) Examiners
Jamie West, North West Anglia NHS Foundation Trust; Sheri Scott, Nottingham Trent University; Jennie Kettlewell, York Teaching Hospital
NHS Foundation Trust and Dr Nigel Brown, Wansbeck General Hospital